Showing 1 - 8 results of 8 for search 'Victor M Oguoma', query time: 0.03s Refine Results
  1. 1
    Letter to editor regarding “Pattern of diabetes mellitus-related complications and mortality rate: Implications for diabetes care in a low-resource setting”

    Letter to editor regarding “Pattern of diabetes mellitus-related complications and mortality rate: Implications for diabetes care in a low-resource setting” by Victor M Oguoma

    Published 2022-01-01
    Get full text
    Article
  2. 2
    Prevalence of overweight and obesity, and associations with socio-demographic factors in Kuwait

    Prevalence of overweight and obesity, and associations with socio-demographic factors in Kuwait by Victor M. Oguoma, Neil T. Coffee, Saad Alsharrah, Mohamed Abu-Farha, Faisal H. Al-Refaei, Fahd Al-Mulla, Mark Daniel

    Published 2021-04-01
    Get full text
    Article
  3. 3
    Metabolically Healthy and Unhealthy Obese Phenotypes among Arabs and South Asians: Prevalence and Relationship with Cardiometabolic Indicators

    Metabolically Healthy and Unhealthy Obese Phenotypes among Arabs and South Asians: Prevalence and Relationship with Cardiometabolic Indicators by Victor M. Oguoma, Mohamed Abu-Farha, Neil T. Coffee, Saad Alsharrah, Faisal H. Al-Refaei, Jehad Abubaker, Mark Daniel, Fahd Al-Mulla

    Published 2022-02-01
    Get full text
    Article
  4. 4
    Cardiovascular disease risk factors in a Nigerian population with impaired fasting blood glucose level and diabetes mellitus

    Cardiovascular disease risk factors in a Nigerian population with impaired fasting blood glucose level and diabetes mellitus by Victor M. Oguoma, Ezekiel U. Nwose, Ifeoma I. Ulasi, Adeseye A. Akintunde, Ekene E. Chukwukelu, Phillip T. Bwititi, Ross S. Richards, Timothy C. Skinner

    Published 2017-01-01
    Get full text
    Article
  5. 5
    HIV/AIDS knowledge and attitudes assessment among women of child-bearing age in South Sudan: Findings from a Household Survey.

    HIV/AIDS knowledge and attitudes assessment among women of child-bearing age in South Sudan: Findings from a Household Survey. by William Mude, Victor M Oguoma, Hailay Abrha Gesesew, Edward K Ameyaw, Carolyne Njue, Tafadzwa Nyanhanda, Adeniyi O Adeleye, Tinashe Dune, Billingsley Kaambwa, Lillian Mwanri

    Published 2020-01-01
    Get full text
    Article
  6. 6
    Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

    Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 month... by Amanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, Paul John Torzillo, Peter McIntyre, Heidi Smith-Vaughan, Nicole Wilson, Beth Arrowsmith, Jemima Beissbarth, Mark D. Chatfield, Victor M. Oguoma, Peter Stanley Morris

    Published 2021-03-01
    Get full text
    Article
  7. 7
    10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial

    10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and s... by Jonathan Carapetis, Paul Torzillo, Heidi Smith-Vaughan, Tom Snelling, Mark Chatfield, Amanda Jane Leach, Ross Andrews, Kim Mulholland, Victor M Oguoma, Nicole Wilson, Peter McIntyre, Anne Balloch, Deborah Lehmann, Michael J Binks, Anne Chang, Vicki Krause, Paul Licciardi, Peter Morris

    Published 2020-05-01
    Get full text
    Article
  8. 8
    Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

    Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) sch... by Amanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, Paul John Torzillo, Peter McIntyre, Heidi Smith-Vaughan, Nicole Wilson, Beth Arrowsmith, Jemima Beissbarth, Mark D. Chatfield, Victor M. Oguoma, Paul Licciardi, Sue Skull, Ross Andrews, Jonathan Carapetis, Joseph McDonnell, Vicki Krause, Peter Stanley Morris

    Published 2021-04-01
    Get full text
    Article

Search Tools: